Michael P. Lunn

National Hospital for Neurology and Neurosurgery

Also affiliated with University College London

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations”.

COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations

Brain(2020)10.1093/brain/awaa444

N/A

0DataRank · unranked

91 citations

David R. Cornblath, Bart C. Jacobs, Luís Querol, P.A. van Doorn, Richard AC Hughes +2 more

Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling

Journal of the Peripheral Nervous System(2021)10.1111/jns.12481

N/A

0DataRank · unranked

11 citations

David Selby, Sam Jones, David Gosal, Timothy Lavin, James B Lilleker +3 more

COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database

medRxiv(2021)10.1101/2021.12.14.21267418

N/A

0DataRank · unranked

18 citations

Sophie Scanlon, Preeti Datta‐Nemdharry, Katherine Donegan, Sally Cavanagh, Mark Foster +8 more

Trajectories of neurodegeneration and seed amplification biomarkers prior to disease onset in individuals at risk of prion disease

medRxiv(2022)10.1101/2022.10.30.22281644

N/A

0DataRank · unranked

0 citations

Akın Nihat, Nour K. Majbour, Danielle Sequeira, Leah Holm-Mercer, Thomas Coysh +28 more

Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease

Brain(2023)10.1093/brain/awad101

N/A

0DataRank · unranked

46 citations

Akın Nihat, Nour K. Majbour, Danielle Sequeira, Leah Holm-Mercer, Thomas Coysh +28 more